Literature DB >> 33360039

Serum biomarkers of cerebral cellular stress after self-limiting tonic clonic seizures: An exploratory study.

Robert Daniel Nass1, Katja Akgün2, Christian Elger3, Heinz Reichmann2, Marcus Wagner4, Rainer Surges3, Tjalf Ziemssen2.   

Abstract

OBJECTIVE: It has been debated for decades whether single, self-limited seizures damage cerebral cells. Meanwhile, very sensitive measurements of biomarkers have become available, i.e. tau, neurofilament protein light (NFL), glial fibrillary acidic protein (GFAP) and ubiquitin carboxyterminate hydrolase L1 (UCHL-1), which we explored in this study.
METHODS: Adult patients of the epilepsy monitoring unit were admitted to the study after written consent. Blood samples were drawn at baseline, immediately after a TCS and after two, six and 24 h. The markers were measured from frozen samples with a single-molecule array (SIMOA).
RESULTS: 20 patients and 20 seizures were included. All markers showed subtle but significant postictal increases and returned to normal within the next few hours (p < 0.05). An increase of at least 100 % from baseline was noted in 30 % of patients for tau, 25 % for UCHL-1 and 15 % for GFAP, while NFL levels never increased above 100 %. Lactate was slightly correlated with the tau increase (r = 0.47, p = 0.037), leukocytes were correlated with postictal changes of GFAP (r = 0.68 p = 0.001).
CONCLUSION: Our data supports the assumption that significant cerebral stress occurs in some but not all self-limited TCS. The postictal inflammatory response in particular seems to play an important role.
Copyright © 2020 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell damage; Cell death; Cell stress; Epilepsy; GFAP; Neurofilament; Seizures

Mesh:

Substances:

Year:  2020        PMID: 33360039     DOI: 10.1016/j.seizure.2020.12.009

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  5 in total

Review 1.  State-of-the-Art Methods and Emerging Fluid Biomarkers in the Diagnostics of Dementia-A Short Review and Diagnostic Algorithm.

Authors:  Eino Solje; Alberto Benussi; Emanuele Buratti; Anne M Remes; Annakaisa Haapasalo; Barbara Borroni
Journal:  Diagnostics (Basel)       Date:  2021-04-27

2.  Serum neurofilament light as biomarker of seizure-related neuronal injury in status epilepticus.

Authors:  Giada Giovannini; Roberta Bedin; Diana Ferraro; Anna Elisabetta Vaudano; Jessica Mandrioli; Stefano Meletti
Journal:  Epilepsia       Date:  2021-11-21       Impact factor: 6.740

Review 3.  Blood GFAP as an emerging biomarker in brain and spinal cord disorders.

Authors:  Ahmed Abdelhak; Matteo Foschi; Samir Abu-Rumeileh; John K Yue; Lucio D'Anna; Andre Huss; Patrick Oeckl; Albert C Ludolph; Jens Kuhle; Axel Petzold; Geoffrey T Manley; Ari J Green; Markus Otto; Hayrettin Tumani
Journal:  Nat Rev Neurol       Date:  2022-02-03       Impact factor: 44.711

4.  CSF and Serum Biomarkers of Cerebral Damage in Autoimmune Epilepsy.

Authors:  Robert Daniel Nass; Katja Akgün; Karmele Olaciregui Dague; Christian Erich Elger; Heinz Reichmann; Tjalf Ziemssen; Rainer Surges
Journal:  Front Neurol       Date:  2021-04-16       Impact factor: 4.003

5.  CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.

Authors:  Mette Scheller Nissen; Matias Ryding; Anna Christine Nilsson; Jonna Skov Madsen; Dorte Aalund Olsen; Ulrich Halekoh; Magnus Lydolph; Zsolt Illes; Morten Blaabjerg
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.